Drug major Cipla on Tuesday said private equity player Fidelity Growth Partners will make investment in its consumer healthcare business. It however did not provide the details of the proposed investment. Cipla's board ‘has approved an investment by Fidelity Growth Partners India and US-based Fidelity Biosciences, through FIl Capital Investments (Mauritius) II ltd or its affiliates in its recently launched consumer healthcare business which is under incorporation,” the company said in a statement. Through the consumer healthcare business, Cipla has entered the over-the-counter (OTC) healthcare market in India, it added. Commenting on the development, Cipla ltd Executive Director Samina Vaziralli said: “Partnering with a long-term strategic and financial investor like Fidelity Growth Partners on this journey will help us create a best-in-class consumer healthcare business.”The investment is subject to execution of definitive pacts, and regulatory approvals, Cipla said.